Transformation beyond reform
A changing life sciences & health care landscape
What lies ahead for global life sciences companies as they focus on the practicalities of dealing with the provisions and impacts of U.S. health care reform?
Deloitte joined senior life science executives, industry leaders, payors, and financers from around the world at the Financial Times U.S. Healthcare and Life Sciences Conference to debate, discuss, and respond to today's critical industry issues.
- Listen to a podcast discussing conference topics, and read related blog perspectives
- New Financing and Business Models for Life Sciences Innovation by Reynold W. (Pete) Mooney, Global LSHC Industry Leader, DTTL
- What is driving life sciences transformation? by Terry Hisey, vice chairman and Life Sciences leader for Deloitte LLP in the United States
- Watch video footage from the 2013 conference